Liver fat during pregnancy may signal future diabetes risk

NCT ID NCT04362540

Ongoing Knowledge-focused Sponsor: University Hospitals of North Midlands NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether fat in the liver, detected by ultrasound during pregnancy, can help predict blood sugar problems after delivery in women with gestational diabetes. Researchers will follow 189 women for 6-12 weeks after birth, measuring insulin resistance and other markers. The goal is to identify those at higher risk early, so they can get closer monitoring and support to prevent type 2 diabetes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help identify women with gestational diabetes who are at higher risk of developing type 2 diabetes, allowing for earlier monitoring and lifestyle changes.
What could go wrong: This is an observational study, not a treatment trial. It is small and short-term, so it cannot prove that liver fat causes diabetes or that any intervention works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL DIABETES

Contacts and locations

Locations

University Hospitals of North Midlands NHS Trust

Stoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.